Non-Hodgkin Lymphoma

Filter By:
07:59
At the iwNHL 2014, Dr Rafael Fonseca interviews Prof Keith Stewart and Prof Leif Bergsagel, all doctors with an interest in myeloma, about the application of myeloma biology and therapies in non-hodgkin lymphoma. Prof Stewart describes tumour heterogeneity and suggests a parallel between myeloma and indolent follicular lymphoma, where the presence ...
by:EMJ | 4 views
10:46
At the iwNHL 2014, Prof John Gribben interviews Prof Wolfram Brugger and Dr Myron Czuczman about the current and future clinical application of targeted or chemotherapy-fr​ee therapies in lymphoma. They discuss their experiences and some of the challenges of these therapies in clinical practice. Impo...
by:EMJ | 6 views
06:46
At the iwNHL 2014, Prof Francesco D'Amore interviews Dr Elaine Jaffe and Prof Laurence de Leval about their involvement at the iwNHL. Dr Jaffe describes the important abnormal contribution of B-cell proliferation in angioimmunoblas​tic T-cell lymphoma and other T-cell lymphomas of follicular T-helper cell derivation. As a result, a neoplastic precur...
by:EMJ | 12 views
07:00
At the iwNHL 2014, Dr Steven Rosen describes the progress made in understanding the biology and management of non-Hodgkin lymphoma. There is now a need to consider new drug combinations to maximise efficacy. Alternatives to chemotherapy including biologic approaches and future research directions in...
by:EMJ | 9 views
07:46
At the iwNHL 2014, Dr Mathias Rummel describes his research investigating the use of bendamustine plus rituximab in treating indolent and mantle-cell lymphomas, highlighting the clinical implications of his long-term findings. He also presents an overview of the progress in other treatment strategie...
by:EMJ | 8 views
07:22
At the iwNHL 2014, Prof John Gribben interviews Prof Randy Gascoyne about the significance of the lymphoma microenvironmen​t in tumour biology and therapy. Understanding the biology of the lymphoma micronenvironme​nt may allow rational therapeutic targeting. Emerging clinical studies in this field are...
by:EMJ | 29 views
02:14
At the iwNHL 2014, Prof John Gribben interviews Prof Randy Gascoyne about the significance of the lymphoma microenvironmen​t in tumour biology and therapy. Improved trial designs, consideration of clinical variables and use of higher resolution approaches are recommended to overcome current research ...
by:EMJ | 37 views
05:53
At the iwNHL 2014, Prof John Gribben interviews Prof Randy Gascoyne about the significance of the lymphoma microenvironmen​t in tumour biology and therapy. It has been increasingly recognised that the interaction between tumour cells and non-tumour cells is essential in disease progression.
by:EMJ | 50 views
12:23
Diffuse large B-cell lymphoma is the most common type of non-Hodgkin lymphoma and it can be aggressive. Drs. John Gribben and Wyndham Wilson discuss new research shows promise for many. Get email alerts | http://www.p... Subscribe on YouTube | http://www.y... Like on Facebook | http://ww......
by:patientpower | 79 views
23:18
Prof John Gribben (Barts Cancer Institute, London, UK) chairs a discussion with Dr Wyndham Wilson (National Cancer Institute, Bethesda, USA), Prof Anton Hagenbeek (Academic Medical Center, Amsterdam, Netherlands), Prof Michael Pfreundschuh (University of Saarland, Homburg-Saar, Germany) and Dr Myron...
by:EMJ | 118 views

Top Tags



Please help us provide the best service.
I'm intersted in oncology videos because I'm a...

Oncologist 
Different type of MD 
Nurse 
Other oncology Professional 
Patient/Advocate 
Something Else 

No Thanks(close window)
Membership has its privileges.
 I want the OncologyTube newsletter 

 I want to share videos & receive the newsletter 

I already have an account log me in.


username:   password: remember me

Sign In

Username:
Password:
Remember me
Forgot your password?
Not Yet a Member? Sign up for FREE here!
(Skip Ad)